Vir Biotechnology, Inc. (VIR) Operating cash flow 2017–2025
Vir Biotechnology, Inc. (VIR) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$391.8MFY2025 · since FY2017: -$66.4M → -$391.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$391.8M | +12.2% |
| FY2024 | -$446.4M | +42.7% |
| FY2023 | -$778.8M | -146.8% |
| FY2022 | $1.7B | +3595.0% |
| FY2021 | -$47.6M | +75.1% |
| FY2020 | -$190.9M | -47.3% |
| FY2019 | -$129.6M | -37.8% |
| FY2018 | -$94.1M | -41.8% |
| FY2017 | -$66.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice